You can buy or sell TYME and other stocks, options, ETFs, and crypto commission-free!
Tyme Technologies, Inc. Common Stock, also called Tyme Technologies, is a biotechnology company, which engages in the development and commercialization of cancer therapies. Read More It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Expected Jul 30, Pre-Market